Kopran Ltd (KOPRAN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 568367, "name": "Kopran", "stock_name": "Kopran", "full_name": "Kopran Ltd", "name_url": "stocks-analysis/kopran", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "191.40", "chg": -4.5, "chgp": "-2.3%", "dir": -1, "prev_price": "195.90", "mcapval": "924.19 Cr", "mcap": "Micro Cap", "scripcode": 524280, "symbol": "KOPRAN", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE082A01010", "curr_date": "Aug 06, 02:16 PM", "curr_time": "14:34 PM", "last_traded_at": "Aug 06, 02:16 PM IST", "bse_nse_vol": "80.84 k", "exc_status": "Active", "traded_date": "Aug 06, 2026", "traded_date_str": "2026 08 06", "score": "", "scoreText": "", "Live": 0, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kopran-568367-1&utm_source=Spage_Header_Score", "mojoone": { "text": "Part of MojoOne Strategy", "type": "HT", "url": "https://www.marketsmojo.com/mojopro/strategy/1", "ismore": 0, "all_data": [], "is_blur": 1, "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kopran-568367-1&utm_source=Spage_Score_PartofStrategies" } }, "news": { "results": [ { "title": "Kopran Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Market Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-ltd-technical-momentum-shifts-signal-bullish-outlook-amid-market-volatility-4139120", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/KopranLtd_technicaldot_4139120.png", "date": "2026-08-06 08:02:48", "description": "Kopran Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, signalling a bullish outlook. The stock’s recent price action, combined with improved technical indicators such as MACD, moving averages, and Bollinger Bands, suggests growing investor confidence amid a broader sector recovery." }, { "title": "Kopran Ltd Locks at Lower Circuit With 5% Loss — Sellers Queue, No Buyers in Sight", "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-ltd-shares-hit-lower-circuit-amid-heavy-selling-pressure-4137656", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/KopranLtd_stocks_hitting_lower_circuit_4137656.png", "date": "2026-08-05 10:00:14", "description": "At Rs 190, sellers were still queuing but no buyers stepped forward, resulting in Kopran Ltd locking at its lower circuit of 5% on 5 Aug 2026. The unfilled supply at the floor price froze trading, underscoring the imbalance between sellers and buyers on this micro-cap stock." }, { "title": "Kopran Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook Amid Market Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-amid-market-volatility-4136919", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/KopranLtd_technicaldot_4136919.png", "date": "2026-08-05 08:03:13", "description": "Kopran Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a slight dip in price, key technical indicators such as MACD and moving averages suggest a cautiously optimistic outlook for investors, even as the stock underperforms the broader Sensex in the short term." }, { "title": "Kopran Ltd Upgraded to Buy by MarketsMOJO on Strong Technical and Financial Recovery", "link": "https://www.marketsmojo.com/news/stock-recommendation/kopran-ltd-upgraded-to-buy-by-marketsmojo-on-strong-technical-and-financial-recovery-4135856", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/KopranLtd_mojoScore_4135856.png", "date": "2026-08-04 08:54:32", "description": "Kopran Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Hold to Buy, reflecting a marked improvement in its technical indicators and financial fundamentals. The upgrade, effective from 3 August 2026, follows a comprehensive reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals, culminating in a MarketsMOJO Mojo Score of 71.0." }, { "title": "Kopran Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-ltd-technical-momentum-shifts-signal-bullish-outlook-amid-mixed-returns-4134676", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/KopranLtd_technicaldot_4134676.png", "date": "2026-08-04 08:05:21", "description": "Kopran Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish trend. Despite a recent dip in daily price, the stock’s technical indicators, including MACD, Bollinger Bands, and moving averages, signal strengthening momentum that could influence investor sentiment amid mixed return performance against the Sensex benchmark." }, { "title": "Kopran Ltd Declines 3.54% Amid Mixed Signals: 2 Key Factors Behind the Week’s Movement", "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-ltd-declines-354-amid-mixed-signals-2-key-factors-behind-the-weeks-movement-4131884", "imagepath": "", "date": "2026-08-01 17:02:17", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Jul:</strong> Stock opens strong at Rs.201.90 (+1.51%) outperforming Sensex</p>\n <p><strong>28 Jul:</strong> Price dips to Rs.199.05 (-1.41%) amid broader market weakness</p>\n <p><strong>29 Jul:</strong> Downgrade to Hold by MarketsMOJO announced</p>\n <p><strong>30 Jul:</strong> Stock falls sharply to Rs.190.40 (-4.35%) on mixed technical signals</p>\n <p><strong>31 Jul:</strong> Partial recovery to Rs.191.85 (+3.06%) with elevated volumes</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-..." }, { "title": "Kopran Ltd Downgraded to Hold by MarketsMOJO Amid Mixed Technical and Financial Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/kopran-ltd-downgraded-to-hold-by-marketsmojo-amid-mixed-technical-and-financial-signals-4128054", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/KopranLtd_mojoScore_4128054.png", "date": "2026-07-30 08:15:38", "description": "Kopran Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 29 July 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technical indicators. Despite recent positive quarterly results, the stock’s technical outlook and valuation relative to peers have prompted a more cautious stance from analysts." }, { "title": "Kopran Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-ltd-technical-momentum-shifts-amid-mixed-market-signals-4127860", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/KopranLtd_technicaldot_4127860.png", "date": "2026-07-30 08:01:23", "description": "Kopran Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a transition from a bullish to a mildly bullish trend. Despite a day decline of 4.35% to close at ₹190.40, the stock’s technical indicators present a nuanced picture, with mixed signals across weekly and monthly timeframes, suggesting cautious optimism for investors navigating this evolving landscape." }, { "title": "Kopran Ltd is Rated Buy by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/kopran-ltd-is-rated-buy-by-marketsmojo-4120141", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/KopranLtd_mojoScore_4120141.png", "date": "2026-07-25 10:10:28", "description": "Kopran Ltd is rated Buy by MarketsMOJO, with this rating last updated on 13 July 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 25 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." } ], "total": 338, "sid": "568367", "stock_news_url": "https://www.marketsmojo.com/news/kopran-568367" }, "announcements": [ { "details": "Kopran Limited has informed the Exchange regarding Disclosure of Related Party Transactions pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended September 30, 2019", "source": "NSE", "caption": "Kopran Limited - Other General Purpose", "datetime": "08-Nov-2019" }, { "details": " <table><tr><td>Kopran Limited has informed the Exchange regarding Board meeting held on September 11, 2019. </td></tr></table>", "source": "NSE", "caption": "Outcome of Board Meeting", "datetime": "11-Sep-2019" }, { "details": " <table><tr><td>Kopran Limited has submitted to the Exchange, the financial results for the period ended June 30, 2019. </td></tr></table>", "source": "NSE", "caption": "Financial Result Updates", "datetime": "08-Aug-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "07 Aug 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Kopran Ltd has declared <strong>30%</strong> dividend, ex-date: 11 Aug 26", "dt": "2026-08-11", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

27 Jul: Stock opens strong at Rs.201.90 (+1.51%) outperforming Sensex

28 Jul: Price dips to Rs.199.05 (-1.41%) amid broader market weakness

29 Jul: Downgrade to Hold by MarketsMOJO announced

30 Jul: Stock falls sharply to Rs.190.40 (-4.35%) on mixed technical signals

31 Jul: Partial recovery to Rs.191.85 (+3.06%) with elevated volumes

Week Open

Read full news article

Kopran Ltd Downgraded to Hold by MarketsMOJO Amid Mixed Technical and Financial Signals

2026-07-30 08:15:38

Kopran Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 29 July 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technical indicators. Despite recent positive quarterly results, the stock’s technical outlook and valuation relative to peers have prompted a more cautious stance from analysts.

Read full news article

Kopran Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-07-30 08:01:23

Kopran Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a transition from a bullish to a mildly bullish trend. Despite a day decline of 4.35% to close at ₹190.40, the stock’s technical indicators present a nuanced picture, with mixed signals across weekly and monthly timeframes, suggesting cautious optimism for investors navigating this evolving landscape.

Read full news article

Kopran Ltd is Rated Buy by MarketsMOJO

2026-07-25 10:10:28

Kopran Ltd is rated Buy by MarketsMOJO, with this rating last updated on 13 July 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 25 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article